21-gene recurrence score and receipt of chemotherapy in patients with breast cancer

Use of the 21-gene recurrence test score was associated with lower chemotherapy use in high-risk patients and greater use of chemotherapy in low-risk patients compared with not using the test among a large group of Medicare beneficiaries, according to a new article.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1hjBfeN